Engineering a Bifunctional Fusion Purine/Pyrimidine Nucleoside Phosphorylase for the Production of Nucleoside Analogs.
biocatalysis
fusion enzymes
nucleoside analogs
nucleoside phosphorylases
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
23 Sep 2024
23 Sep 2024
Historique:
received:
28
08
2024
revised:
17
09
2024
accepted:
17
09
2024
medline:
28
9
2024
pubmed:
28
9
2024
entrez:
28
9
2024
Statut:
epublish
Résumé
Nucleoside phosphorylases (NPs) are pivotal enzymes in the salvage pathway, catalyzing the reversible phosphorolysis of nucleosides to produce nucleobases and α-D-ribose 1-phosphate. Due to their efficiency in catalyzing nucleoside synthesis from purine or pyrimidine bases, these enzymes hold significant industrial importance in the production of nucleoside-based drugs. Given that the thermodynamic equilibrium for purine NPs (PNPs) is favorable for nucleoside synthesis-unlike pyrimidine NPs (PyNPs, UP, and TP)-multi-enzymatic systems combining PNPs with PyNPs, UPs, or TPs are commonly employed in the synthesis of nucleoside analogs. In this study, we report the first development of two engineered bifunctional fusion enzymes, created through the genetic fusion of purine nucleoside phosphorylase I (PNP I) and thymidine phosphorylase (TP) from
Identifiants
pubmed: 39334962
pii: biom14091196
doi: 10.3390/biom14091196
pii:
doi:
Substances chimiques
Purine-Nucleoside Phosphorylase
EC 2.4.2.1
Pyrimidine Phosphorylases
EC 2.4.2.-
Recombinant Fusion Proteins
0
Nucleosides
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Santander Foundation
ID : 2020/UEM42
Organisme : Spanish Ministry of Science, Innovation, and Universities.
ID : PID2020-117025RB-I00